Figure 3: PHF5A-Y36C protects against splicing modulator induced mis-splicing.

(a) In vitro splicing assay in the presence of indicated splicing modulators in nuclear extracts containing WT or Y36C PHF5A. Error bar indicates s.d., n=4. (b) Taqman gene expression analysis of mature SLC25A19 mRNA levels and EIF4A1 pre-mRNA levels in either WT- or Y36C PHF5A-expressing cells treated with indicated splicing modulators. All data points were normalized to the corresponding DMSO-treated control samples and displayed in logarithmic scale on the y axis. Error bar indicates s.d., n=2.